Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Biotech has informed stock exchanges that its trading window will be closed from Tuesday, 1st July 2025 until 48 hours after the announcement of its Q1 FY26 financial results (quarter ended 30th June 2025). This is a standard compliance filing under SEBI's Insider Trading Regulations, 2015 and the company's own code of conduct. The date of the board meeting to consider and approve the Q1 results has not yet been disclosed and will be communicated later. The intimation was signed by Aman Patel, Director of the company.
This is a routine regulatory compliance filing with no material impact on the stock. During the closed period, insiders such as directors, key managerial personnel, and their immediate relatives are prohibited from trading in the company's shares until results are publicly announced.